<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="vaccines-07-00053-t002" orientation="portrait" position="float">
 <object-id pub-id-type="pii">vaccines-07-00053-t002_Table 2</object-id>
 <label>Table 2</label>
 <caption>
  <p>Influenza antiviral drugs approved or in clinical trials.</p>
 </caption>
 <table frame="hsides" rules="rows">
  <thead>
   <tr>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Antiviral</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Mechanism of Action</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Clinical Phase and Status</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Country of Development/Trial</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">Das181 (Fludase)</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Sialic acid removal in the respiratory airways</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">II (IFV), III (PIV) not yet recruiting</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">USA</td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">Nitazoxanide</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">HA maturation inhibition</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">III completed</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">USA</td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">JNJ-63623872 (Pimodivir)</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Small molecule inhibitor of influenza A virus PB2</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">III recruiting</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Belgium</td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">T705 (Favipiravir)</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">RNA-dependent RNA polymerase inhibitor</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">IV</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Japan</td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">Baloxavir marboxil</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Small molecule inhibitor of cap-dependent endonuclease (PA)</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">III recruiting children &lt;1 year 
     <sup>1</sup>
    </td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Japan</td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">Arbidol (Umifenovir)</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">HA resistance to conformational changes triggered by pH</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">III recruiting in China/IV unknown status in Russia</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">China; Russia</td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ingavirin</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Interaction with NP and inhibition of viral genome release</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IV completed</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Russia</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn>
   <p>Note: Drugs and their clinical statuses were adapted from the 
    <uri>clinicaltrials.gov</uri>. 
    <sup>1</sup> Approved for treatment of acute uncomplicated influenza among â‰¥12 years 
   </p>
  </fn>
 </table-wrap-foot>
</table-wrap>
